Cuillerot Jean-Marie 4
4 · Acrivon Therapeutics, Inc. · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Cuillerot Jean-Marie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-11+99,300→ 99,300 totalExercise: $4.82Exp: 2034-01-10→ Common Stock (99,300 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2025, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.